2015
DOI: 10.4172/2157-7439.1000338
|View full text |Cite
|
Sign up to set email alerts
|

Chemically Grown MoO3 Nanorods for Antibacterial Activity Study

Abstract: In the present investigation, sea urchin like morphology of h-MoO 3 nanorods are successfully synthesized by chemical bath deposition (CBD) technique. The thermal stability, structural details, morphology and compositional analysis of MoO 3 was done using thermogravimetry (TGA), X-ray diffraction (XRD), scanning electron microscopy (SEM), high resolution transmission electron microscopy (HR-TEM), selected area electron diffraction (SAED) and X-ray photoelectron spectroscopy (XPS) techniques respectively. The t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(24 citation statements)
references
References 43 publications
0
23
0
Order By: Relevance
“…According to Sudlow's nomenclature, HSA appears to have two specific drug‐binding sites, namely site I (also called the warfarin binding site) and site II (the benzodiazepine binding site) . Consequently, to improve the pharmacokinetic profile and the therapeutic efficiency, and reduce the side effects of drugs, different types of chemotherapeutic drugs, anti‐inflammatory drugs, hypoglycemic drugs, and a number of other types, may have high affinity to the two binding sites of HSA. After loading with drug molecules, especially water‐insoluble ones such as PTX, nanoparticles with sizes in the range of 50–150 nm are often formed owing to the self‐assembly of many albumin proteins into a single nanoparticle…”
Section: Albumin In Drug Deliverymentioning
confidence: 99%
“…According to Sudlow's nomenclature, HSA appears to have two specific drug‐binding sites, namely site I (also called the warfarin binding site) and site II (the benzodiazepine binding site) . Consequently, to improve the pharmacokinetic profile and the therapeutic efficiency, and reduce the side effects of drugs, different types of chemotherapeutic drugs, anti‐inflammatory drugs, hypoglycemic drugs, and a number of other types, may have high affinity to the two binding sites of HSA. After loading with drug molecules, especially water‐insoluble ones such as PTX, nanoparticles with sizes in the range of 50–150 nm are often formed owing to the self‐assembly of many albumin proteins into a single nanoparticle…”
Section: Albumin In Drug Deliverymentioning
confidence: 99%
“…We specifically examined the hydrophobicity of rare-earth oxides [ [8] , [9] , [10] , [11] , [12] ] and antibacterial effects of molybdenum [ [13] , [14] , [15] , [16] ]. Then we developed the complex oxide La 2 Mo 2 O 9 (hereinafter LMO) using polymerizable complex method [ 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…Clinically‐used ANPs ( nab‐ paclitaxel, Abraxane, Abraxis BioScience Inc.)38, 39 have already been shown to sequester large amounts of therapeutic cargo,40, 41 improve the pharmacokinetics and circulation half‐life of antitumor agents,42 reduce in vivo toxicity associated with solvent delivery systems21 and possibly enhance tumor uptake of therapeutics via albumin binding interactions 43–45. However, ANPs exhibit limited penetration into tumors and have not yet been reported to deliver a combination of synergistic chemotherapeutics simultaneously.…”
Section: Discussionmentioning
confidence: 99%